Skip to content

Towards a comprehensive package of preventive and palliative care

HPV vaccination doesn't help to clear the virus in women already infected

First fixed dose combination for children approved for PEPFAR use

Abbott warns on risk of overdose with Kaletra liquid

Use CD4 cell count, not CD4 cell percentage to guide treatment decisions in all patients with HIV, even those with cirrhosis

IAS: Maraviroc produces best results when combined with another active drug

IAS: Boosted atazanavir shows edge over unboosted in treatment-naive after 96 weeks

Were host factors or superinfection the key to case of rapid HIV progression?

Over 50s do just as well on HIV treatment, but more likely to be diagnosed late and to change treatment sooner